Pricing Log in Create free account

Eikon Therapeutics, Inc. (EIKN) vs Galectin Therapeutics Inc. (GALT)

Eikon Therapeutics, Inc. and Galectin Therapeutics Inc. are both Biotechnology companies. Eikon Therapeutics, Inc. and Galectin Therapeutics Inc. are of similar size ($316.3M and $301.0M). Across the 8 metrics below, Galectin Therapeutics Inc. leads on 6 and Eikon Therapeutics, Inc. on 2.

Valuation

Metric EIKN GALT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.69 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.62 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (1,147.55%) (13.69%) (32.88%)
Free cash flow yield (138.83%) (7.68%) (23.13%)

Profitability

Metric EIKN GALT Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 21.69% (51.96%)
Return on assets (90.08%) (184.22%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EIKN GALT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (19.15%) 36.84% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EIKN GALT Biotechnology median
Debt to equity 0.00 (0.76) 0.00
Current ratio 9.89 0.10 4.97
Net debt to EBITDA 1.07 (5.79) 1.01

Dividend

Metric EIKN GALT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EIKN GALT Biotechnology median
Market cap 316.32m 301.04m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack